Physician profile
David Lee
NPI 1659534667
$1,296.82
in general payments reported to CMS, 2019-2025
10 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2022: $19.92 · 2023: $647 · 2024: $219 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Travel and Lodging: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.35 |
| Travel and Lodging | $464.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $439.00 | 2023 | Organ Care System |
| Xvivo Perfusion INC. | $222.39 | 2025 | Xvivo Perfusion System (Xps) |
| Abbott Laboratories | $137.44 | 2024 | Proclaim |
| Veloxis Pharmaceuticals, INC. | $123.92 | 2022-2023 | Envarsus |
| Boston Scientific Corporation | $104.40 | 2023 | Advantage System |
| Medtronic, INC. | $81.31 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $71.99 | 2019 | |
| Mallinckrodt Enterprises LLC | $71.99 | 2019 | |
| Genzyme Corporation | $24.57 | 2019 | |
| Intuitive Surgical, INC. | $19.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.